Showing results (281-290 of 530) with videos related to
Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|June 18, 2021
Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trialsAlexander P Benz, Isabelle Johansson, Willem J M Dewilde, et al.European Heart Journal. Cardiovascular Pharmacotherapy|May 18, 2022
Associations between medical therapy after surgical aortic valve replacement for aortic stenosis and long-term mortality: a report from the SWEDEHEART registryJulia Baranowska, Charlotta Törngren, Susanne J Nielsen, et al.European Heart Journal. Cardiovascular Pharmacotherapy|June 26, 2019
PCSK9 and inflammation: a review of experimental and clinical evidenceAmir Abbas Momtazi-Borojeni, Sarvenaz Sabouri-Rad, Antonio M Gotto, et al.European Heart Journal. Cardiovascular Pharmacotherapy|July 28, 2018
A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillationA John Camm, Paul Dorian, Stefan H Hohnloser, et al.European Heart Journal. Cardiovascular Pharmacotherapy|September 8, 2018
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysisMagnus Dahl Aarvik, Irene Sandven, Tatendashe B Dondo, et al.European Heart Journal. Cardiovascular Pharmacotherapy|July 19, 2018
Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.European Heart Journal. Cardiovascular Pharmacotherapy|June 27, 2018
Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide studyCaroline Sindet-Pedersen, Laila Staerk, Jannik Langtved Pallisgaard, et al.European Heart Journal. Cardiovascular Pharmacotherapy|May 24, 2019
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on StrokePatrick Sulzgruber, Sven Wassmann, Anne Grete Semb, et al.European Heart Journal. Cardiovascular Pharmacotherapy|March 2, 2022
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trialSlayman Obeid, Peter Libby, Elaine Husni, et al.European Heart Journal. Cardiovascular Pharmacotherapy|April 20, 2022
The effect of CETP inhibitors on new-onset diabetes: a systematic review and meta-analysisKaterina Dangas, Ann-Marie Navar, John J P KasteleinPageof 53